FREMONT, Calif. and TAIZHOU, China, July 30, 2025 (GLOBE NEWSWIRE) — Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), and Genecast (Taizhou) Biotechnology Co., Ltd., a pioneering oncology diagnostics company, today announced a strategic global partnership to accelerate access to cutting-edge molecular diagnostic technologies for cancer care worldwide. This […]

(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr: ORN), Between December 2024 and July 2025, Oryzon secured financing totaling EUR52 M, approx. $61 M (EUR30.0 M from a capital increase, EUR7.0 M from commercial bank loans, EUR13.2 M from the EU-IPCEI grant, and EUR1.8 M from R&D cash-back incentives) Company has terminated the Convertible Bonds financing facility with Nice&Green

(NASDAQ:BGLC), KUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC“, Nasdaq: BGLC) and Fidelion Diagnostics Pte Ltd, a Singaporean company (“Fidelion“) today announced the signing of a term sheet for a strategic, cross-equity partnership that the parties are calling a “DeepSeek-class leap” for liquid biopsy cancer monitoring and AI-driven biotechnology. This builds on BGLC's

ALHAMBRA, Calif., July 30, 2025 (GLOBE NEWSWIRE) — HieFo Corporation, a leader in InP-based optical chip innovation, today announced the commercial release of its new HOT25 Specialty Distributed Feedback (DFB) Laser Chip–engineered specifically for Optical Time Domain Reflectometer (OTDR) applications in fiber optic test and measurement equipment. Like most other products in HieFo's portfolio, the

(TSX:PXT), CALGARY, Alberta, July 30, 2025 (GLOBE NEWSWIRE) — Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce its financial and operating results for the three-month period ended June 30, 2025, the declaration of its Q3 2025 regular dividend of C$0.385 per share, as well as an operational update. All amounts

(NasdaqGM:PFSA), BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces its initial $1 million Bitcoin (BTC) investment under its previously reported treasury strategy. The company intends

(NASDAQ:BNGO), SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (NASDAQ: BNGO) recently participated in the European Cytogenomics Conference, which is the biennial meeting of the European Cytogenomics Association (ECA). The conference was held in Leuven, Belgium, from June 29 – July 1 and attracted leading scientists, clinicians, cytogeneticists and laboratory directors from

(TSX-V:SAGA),(Boerse Frankfurt – Freiverkehr:20H),(OTC US:SAGMF),(Other OTC:SAGMF), VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discovery, is pleased to announce SAGA's team has completed the 4 km access trail along the core of

(NASDAQ:NAUT), • Allen Institute to employ Iterative Mapping, Nautilus' single-molecule proteomics method, to investigate connection between tau protein and Alzheimer's disease • Agreement links the organizations' next-generation proteomics technology and neuroscience leadership to potentially unlock breakthrough therapeutics and biomarkers for neurodegenerative disease SEATTLE, July 30, 2025 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or

-Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology Innovation Source (OIS) Retina 8th Annual Innovation Summit -VLTR-559, a long-acting anti-VEGF therapy, could reduce dosing frequency for the treatment of wet AMD to twice-yearly, as compared to every eight to twelve weeks for standard-of-care anti-VEGFs -Valitor plans to enter clinical testing of